2.2. Endpoints

RJ Rafał Januszek
ZS Zbigniew Siudak
KM Krzysztof P. Malinowski
RW Roman Wojdyła
PM Piotr Mika
WW Wojciech Wańha
TK Tomasz Kameczura
AS Andrzej Surdacki
WW Wojciech Wojakowski
JL Jacek Legutko
SB Stanisław Bartuś
request Request a Protocol
ask Ask a question
Favorite

The primary aim of this study was to assess the frequency of TA according to the type of MI in patients treated with pPCI as well as NRP and stroke. The secondary study endpoints included the assessment of possible predictors of TA use and NRP occurrence.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A